We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Whitepaper

High-Throughput, Multi-Parametric Analysis Accelerates Antibody Discovery Workflows

Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on binding, antibody internalization and antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation.
Whitepaper

CRISPR Antibiotics: Turning Defense Into Offence

Download this whitepaper to discover how CRISPR can overcome antibiotic-resistant and pathogenic bacteria.
Whitepaper

Reagent Manufacturing for a Novel CRISPR-Based Diagnostic SARS CoV-2 Test

Download this whitepaper to discover how the manufacturing process was successfully scaled using operational support, a customized solution as well as a highly collaborative and strategic engagement.
Whitepaper

Respiratory Syncytial Virus Antigens and Antibodies

Respiratory syncytial virus (RSV) has a high mortality rate and is the leading cause of lower respiratory tract infections in children and infants worldwide.
Whitepaper

How CRISPR Can Help the Switch to Sustainable Cosmetics

The global cosmetics industry is worth more than $500 billion, but relies on ingredients that are unsustainable and cause harm to plant and animal life. Growing awareness of this problem among consumers has fueled a demand for something different.
Whitepaper

Key Trends in Lab Automation 2022

Despite the increasing adoption of lab automation in the sciences, in 2022, awareness about what it can truly do remains frustratingly limited, with most labs mistaking partial automation to mean a lab is fully automated, and other labs with fully integrated automation systems losing out on flexibility.
Whitepaper

Advanced Reagents for SARS-CoV-2 Neutralizing Antibody Detection

The COVID-19 pandemic has continued to spread worldwide, with an increasing number of global infections and the continual emergence of new variants. Are the existing vaccines still effective against new variants?
Whitepaper

Quality Assurance in IVT RNA Vaccine Development

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments
Whitepaper

Streamline Antibody Labeling Workflows

Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.
Whitepaper

Improving Efficiency in Drug Discovery and Preclinical Development

Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.
Advertisement